| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 4 | 5 | 2 | — | — | — | — | — | — | — | — | — |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Cash | 6.14 | 1.46 | 1.24 | 1.33 |
| Receivables | — | — | 0.08 | 0.10 |
| Inventory | 0.06 | 0.07 | 0.14 | 0.23 |
| Other | — | — | — | — |
| 6.20 | 1.54 | 1.46 | 3.06 |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Payables | 0.74 | 0.65 | 0.84 | 0.97 |
| ST’ Debt | 0.04 | 0.01 | 0.01 | 0.01 |
| Other | 0.17 | 0.02 | 0.73 | 0.22 |
| 1.99 | 3.27 | 6.04 | 5.36 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡ | ‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3.51 | 3.69 | — | — |
—
|
| ’24 | 2.81 | 3.33 | 3.02 | 3.69 |
12.84
|
| ’23 | 2.48 | 2.21 | 2.03 | 2.50 |
9.21
|
| ’22 | 2.04 | 1.94 | 1.77 | 2.54 |
8.28
|
| ’21 | — | — | 1.84 | — |
6.54
|
| ’20 | — | — | — | — |
3.17
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.86) | (0.90) | — | — |
—
|
| ’24 | (0.37) | 0.99 | 0.54 | (0.29) |
0.88
|
| ’23 | (1.77) | (0.78) | (0.76) | (1.28) |
(4.59)
|
| ’22 | (0.38) | (0.51) | (2.45) | (0.47) |
(3.80)
|
| ’21 | — | — | 0.31 | (0.11) |
0.19
|
| ’20 | — | — | — | 0.13 |
0.13
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.90) | (1.12) | — | — |
—
|
| ’24 | (0.73) | 0.95 | 0.50 | (0.61) |
0.11
|
| ’23 | (2.71) | (0.88) | (1.06) | (1.41) |
(6.06)
|
| ’22 | (0.56) | (0.61) | (2.62) | (1.48) |
(5.27)
|
| ’21 | — | — | (0.51) | (0.20) |
(0.70)
|
| ’20 | — | — | — | (0.41) |
(0.41)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.24) | (1.00) | — | — |
—
|
| ’24 | (0.16) | (0.20) | (0.23) | 0.10 |
(0.49)
|
| ’23 | (0.25) | (0.20) | (0.17) | — |
0.57
|
| ’22 | — | — | (0.37) | (0.22) |
0.83
|
| ’21 | — | — | — | — |
(0.87)
|
| ’20 | — | — | — | — |
(0.33)
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 2.53 | 0.74 | 0.68 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | 16.25 | 6.47 | 2.12 | — | — | — |
High Price
|
| — | — | — | — | — | — | ‡‡‡‡‡ | 130 | 180 | 259 | — | — | — |
Employees
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 0.06 | 0.05 | 0.05 | — | — | — |
Revenue/Emp
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.28 | 9.21 | 12.84 | — | — | — |
Revenue
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.01% | 3.95% | 11.81% | — | — | — |
Gross Margin
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.47) | (2.99) | (2.63) | — | — | — |
EBT
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (41.87%) | (32.47%) | (20.50%) | — | — | — |
EBT Margin
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.49) | (3.04) | (2.67) | — | — | — |
Net Income
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.66 | 0.55 | 0.86 | — | — | — |
Depreciation
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.92 | 1.73 | 2.39 | — | — | — |
Revenue/Sh
|
| — | — | — | — | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.83 | 0.57 | (0.49) | — | — | — |
Earnings/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.88) | (0.86) | 0.16 | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.34) | (0.28) | (0.14) | — | — | — |
Capex/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.22) | (1.14) | 0.02 | — | — | — |
Free CF/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.31 | 0.50 | 0.05 | — | — | — |
Book Value/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.31 | 5.32 | 5.38 | — | — | — |
Shares
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | 1.85 | 0.98 | 0.34 | — | — | — |
PS Ratio
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | 2.72 | 3.41 | 17.28 | — | — | — |
PB Ratio
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | 1.29 | 0.98 | 0.56 | — | — | — |
EV/Sales
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.02) | (1.48) | 62.76 | — | — | — |
EV/FCF
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.80) | (4.59) | 0.88 | — | — | — |
Op' Cash Flow
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.47) | (1.47) | (0.76) | — | — | — |
Capex
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.27) | (6.06) | 0.11 | — | — | — |
FCF
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.21 | (1.73) | (4.58) | — | — | — |
Working Cap'
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.47 | 1.42 | 3.96 | — | — | — |
Total Debt
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.67) | (0.04) | 2.72 | — | — | — |
Net Debt
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.64 | 2.65 | 0.26 | — | — | — |
Sh' Equity
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (31.92%) | (20.94%) | (17.43%) | — | — | — |
ROA
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | (244.03%) | (84.21%) | (53.63%) | — | — | — |
ROIC
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (210.13%) | (73.34%) | (183.29%) | — | — | — |
ROE
|
Vestand Inc. (VSTD) has posted impressive revenue growth of nearly 40% year-over-year to $12.8 million in 2024, driven by workforce expansion and stabilizing productivity around $50,000 per employee, signaling potential product-market fit in emerging markets amid post-pandemic shifts. Gross margins have rebounded to 12%, and free cash flow turned positive for the first time at $114,000, narrowing losses and hinting at operational leverage. Yet, the stock remains battered, down over 98% from 2022 peaks, trading at deeply compressed multiples like 0.34x price-to-sales, which could represent value—if fundamentals hold.
Balance sheet risks temper the optimism: debt has doubled to $3.96 million, working capital swung to a deficit, and book value per share plummeted 91% amid dilution. Insider selling by a major holder adds caution, with no buys amid price weakness, while persistent EBT losses at -21% margin underscore profitability hurdles in a volatile micro-cap environment sensitive to rates and macro pressures.
This setup offers asymmetric potential for steady performers willing to navigate risks, but demands scrutiny of debt servicing and execution. The full analysis dives deeper into trajectories, valuations, and scenarios to assess if VSTD can steady its course or face further downside.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.